Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Dec;15(6):2842-2851.
doi: 10.1002/jcsm.13645. Epub 2024 Nov 8.

Clinical Impact of Sarcopenia Screening on Long-Term Mortality in Patients Undergoing Coronary Bypass Grafting

Affiliations
Observational Study

Clinical Impact of Sarcopenia Screening on Long-Term Mortality in Patients Undergoing Coronary Bypass Grafting

Seung Hun Lee et al. J Cachexia Sarcopenia Muscle. 2024 Dec.

Abstract

Background: Sarcopenia is an aging-related condition characterized by loss of skeletal muscle mass and is an indicator of subclinical atherosclerosis. The relationship between reduced muscle mass and long-term clinical outcomes in patients with advanced coronary artery disease who have undergone coronary artery bypass grafting (CABG) is not fully understood. This study is sought to evaluate the prognostic implications of sarcopenia screening in patients undergoing CABG.

Methods: A total of 2810 patients who underwent CABG were analysed and classified according to presence of reduced muscle mass. The skeletal muscle index (SMI) was calculated as L3 muscle area (cm2)/height (m)2 on computed tomography. Reduced SMI was defined as SMI ≤ 45 cm2/m2 in male and ≤ 38 cm2/m2 in female. The primary outcome was all-cause mortality, and survival analysis was performed using the Kaplan-Meier method and compared with the log-rank test.

Results: The median follow-up was 8.7 years, and 924 patients (32.9%) had reduced SMI. Patients with reduced SMI were older (67.7 ± 8.8 vs. 62.2 ± 9.8 years; p < 0.001) and less frequently male (69.8% vs. 81.1%; p < 0.001). SMI was significantly associated with risk of death on a restricted cubic spline curve (HR = 1.04 per-1 decrease; 95% CI 1.03-1.05; p < 0.001). Patients with reduced SMI had a higher incidence of long-term mortality than those with preserved SMI (survival rate 41.4% vs. 62.8%; HRadj = 1.18, 95% CI 1.03-1.36, p = 0.020). Subgroup analysis showed that the prognostic implication of reduced SMI on long-term survival was more evident in male (HRadj = 2.01, 95% CI 1.72-2.35) than female (HRadj = 1.28, 95% CI 0.98-1.68) (interaction p = 0.006).

Conclusions: Reduced muscle mass, defined by SMI on computed tomography, was associated with long-term mortality after CABG. These results provide contemporary data to allow the evaluation of physical frailty in patients with advanced coronary artery disease before surgery.

Trial registration: Long-Term Outcomes and Prognostic Factors in Patients Undergoing CABG or PCI: NCT03870815.

Keywords: coronary artery bypass grafting; coronary artery disease; frailty; prognosis; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Study flow. CABG = coronary artery bypass grafting; CT = computed tomography; SMI = skeletal muscle index.
FIGURE 2
FIGURE 2
Kaplan–Meier curve for clinical outcomes according to SMI. The survival probability of (A) all‐cause death and (B) MACCE were compared according to the presence reduced SMI. MACCE = major adverse cardiac and cerebrovascular event.
FIGURE 3
FIGURE 3
Subgroup analysis of death during a median 8.7‐year follow‐up. Subgroup analysis demonstrated a differential prognostic impact of reduced SMI between male and female. AMI = acute myocardial infarction; CABG = coronary artery bypass grafting; CI = confidence interval; IHD = ischemic heart disease; LVEF = left ventricular ejection fraction.

Similar articles

Cited by

References

    1. Head S. J., Kieser T. M., Falk V., Huysmans H. A., and Kappetein A. P., “Coronary Artery Bypass Grafting: Part 1—The Evolution Over the First 50 Years,” European Heart Journal 34 (2013): 2862–2872. - PubMed
    1. Lawton J. S., Tamis‐Holland J. E., Bangalore S., et al., “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” Journal of the American College of Cardiology 79 (2022): e21–e129. - PubMed
    1. Pu A., Ding L., Shin J., et al., “Long‐Term Outcomes of Multiple Arterial Coronary Artery Bypass Grafting: A Population‐Based Study of Patients in British Columbia, Canada,” JAMA Cardiology 2 (2017): 1187–1196. - PMC - PubMed
    1. McNeely C., Markwell S., and Vassileva C., “Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population,” The Annals of Thoracic Surgery 102 (2016): 132–138. - PubMed
    1. Hardiman S. C., Villan Villan Y. F., Conway J. M., Sheehan K. J., and Sobolev B., “Factors Affecting Mortality After Coronary Bypass Surgery: A Scoping Review,” Journal of Cardiothoracic Surgery 17 (2022): 45. - PMC - PubMed

Publication types

Associated data